Zusammenfassung
In-vitro-Nachweis der Hemmung der Proteo- und Nukleosynthese in den EAC-Zellen, sowie des Wachstums der HeLa-Zellen mit folgenden Derivaten des Tetrazyklins: Anhydrotetrazyklin, 4α, 12α-Anhydrodedimethylaminotetrazyklin und 12α-Deoxydedimethylaminotetrazyklin.
References
V. I. Vdovičenko, Antibiotiki14, 18 (1969).
V. I. Vdovičenko, Antibiotiki15, 15 (1970).
V. I. Vdovičenko, Antibiotiki15, 50 (1970).
J. Kennt, US patent No. 3326 761.
J. Fuska, M. Podojil, A. Fusková andZ. Vanèk, Symposium an Mechanisms of Action of Cytostatic Agents (Abstract Books, Budapest 1972), p. 24.
J. R. D. McCornick, P. A. Miller, S. Johnson, N. H. Arnold andN. O. Sjolander, J. Am. chem. Soc.84, 3023 (1962).
R. C. Ewans,The Technology of the Tetracyclines (Quadrangle Press, New York 1968), p. 350.
R. Broschard andG. Krupka, US patent No. 2744931.
A. Green, R. C. Wilkinson andJ. H. Boothe, J. Am. chem. Soc.82, 3946 (1960).
J. Fuska, M. Miko, P. Nemec andĽ. Drobnica, Neoplasma18, 631 (1971).
V. I. Oyama andH. Eagle, Proc. Soc. exp. Biol. Med.91, 305 (1956).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fuska, J., Podojil, M., Fusková, A. et al. The effects of some tetracycline derivates on Ehrlich ascites carcinoma and HeLa cells in vitro. Experientia 30, 403–404 (1974). https://doi.org/10.1007/BF01921688
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01921688